Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

Every year, my colleagues and I put together a list of what we think are the top 10 breakthrough technologies of that year.

When volunteers launched Pittsburgh Aids Task Force in 1985, they didn’t expect the organization would be operating 40 years later.

A new study led by Western researchers is the first to identify a factor that could influence how fast the pocket where human ...

One potential solution is HIV self-testing, which would allow for rapid identification and treatment. Identifying HIV cases is the first step in addressing clusters, and quickly learning one’s ...

Priscilla Tsondai, MD, MPH, breaks down top care gaps as opportunities for care improvement.

HIV/AIDS continues to disproportionately affect Black Americans, despite overall progress in reducing infection rates.

HIV prevention has advanced with lenacapavir, a yearly injection that blocks the virus's replication, providing long-term protection. If this yearly injection is approved and widely implemented ...

For decades, external actors, such as donors, funders, and implementing partners, have shaped Africa's HIV response. Although this strategy has saved millions of lives, it entrenched dependency, ...

Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study by researchers ...

Public health experts and HIV prevention advocates agree that voluntary medical male circumcisions — a procedure where a ...

As more heterosexual people are diagnosed with HIV, sexual health stigmas among Māori are putting wahine at risk, a Rotorua health advocate says. “It’s a tapu subject,” said Milly Stewart ...